Pneumococcal Vaccination in Children with Cancer

Te-Yu Hung

Research output: ThesisMaster's Thesis

51 Downloads (Pure)

Abstract

Children with cancer receiving immunosuppressive therapy are vulnerable to severe pneumococcal disease (IPD). This thesis examines the role of the 13-valent pneumococcal conjugate vaccine (PCV13) in children undergoing (AIT) or recently completed immunosuppressive cancer therapy (CIT) to prevent and reduce IPD. A prospective, open-label cohort study included children with cancer given a dose of PCV13 demonstrated satisfactory immunogenic responses and low rate of serious adverse events. Our study design was suboptimal to evaluate vaccination and its role for preventing nasopharyngeal colonization.
Original languageEnglish
QualificationMasters
Awarding Institution
  • The University of Western Australia
Award date28 Aug 2018
DOIs
Publication statusUnpublished - 2018

Fingerprint Dive into the research topics of 'Pneumococcal Vaccination in Children with Cancer'. Together they form a unique fingerprint.

Cite this